Skip to content
HowShorted

ASSEMBLY BIOSCIENCES, INC. short interest in 2021

In 2021, ASSEMBLY BIOSCIENCES, INC.'s disclosed short interest ran from 7.88% of shares outstanding on 15 Jan 2021 to 2.39% on 31 Dec 2021, a change of -5.49 percentage points. The year's high was 14.73% on 30 Apr 2021 and its low 2.39% on 31 Dec 2021, averaging 7.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.51 days on 28 May 2021. Full history: ASSEMBLY BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ASSEMBLY BIOSCIENCES, INC. in 2021

2021 in figures

Start of year
7.88% (15 Jan 2021)
End of year
2.39% (31 Dec 2021)
Change
-5.49 pp
High
14.73% (30 Apr 2021)
Low
2.39% (31 Dec 2021)
Average
7.64%
Highest days to cover
7.51 (28 May 2021)
SEC filings marked
8

Every report in 2021

ASSEMBLY BIOSCIENCES, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20217.88%4.68
29 Jan 20217.22%2.45
12 Feb 20217.54%1.41
26 Feb 202111.71%2.6310-K filed, results (8-K)
15 Mar 202111.10%2.24
31 Mar 202112.80%4.11
15 Apr 202112.19%7.20
30 Apr 202114.73%5.95
14 May 202111.13%6.5010-Q filed, results (8-K)
28 May 202111.69%7.51
15 Jun 202112.72%3.65
30 Jun 202111.89%2.47
15 Jul 202110.46%2.79
30 Jul 20217.18%3.96
13 Aug 20216.19%3.1010-Q filed, results (8-K)
31 Aug 20213.59%2.08
15 Sep 20213.52%1.24
30 Sep 20213.23%2.97
15 Oct 20212.52%2.16
29 Oct 20213.12%3.73
15 Nov 20212.67%1.4910-Q filed, results (8-K)
30 Nov 20213.25%1.00
15 Dec 20212.73%1.81
31 Dec 20212.39%1.19

See also: ASSEMBLY BIOSCIENCES, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.